Remed Co.,Ltd. (KOSDAQ:302550)
South Korea
· Delayed Price · Currency is KRW 3,180.00
+5.00 (0.16%)
At close: Mar 6, 2026
Remed Revenue
Remed had revenue of 5.81B KRW in the quarter ending September 30, 2025, a decrease of -3.69%. This brings the company's revenue in the last twelve months to 24.26B, up 3.56% year-over-year. In the year 2024, Remed had annual revenue of 25.55B with 37.86% growth.
Revenue (ttm)
24.26B
Revenue Growth
+3.56%
P/S Ratio
3.92
Revenue / Employee
263.65M
Employees
92
Market Cap
95.19B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SELVAS Healthcare | 29.79B |
| Noul Co.,Ltd. | 3.91B |
| QuantaMatrix | 3.35B |
| Hironic | 33.18B |
| Neofect | 20.50B |
| JPI Healthcare | 52.79B |
| DRGEM | 98.34B |
| Genoray | 102.75B |